Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Bradbury D, King ED, Eddy H, Kyprianou N (1996) BCL-2 over expression delays radiation induced apoptosis in human prostate cancer cells. J Urol 155:215 (Abstract 796)
2. Brausi M, Jones WG, Fosså SD, et al (1995) High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC GU-Group. Eur J Cancer 31A:1622
3. Collste LG (1990) Second line treatment in hormone refractory prostate cancer. In: Newling DWW, Jones W (eds) EORTC GU-Group Monograph 7, prostate cancer and testicular cancer. Wiley Liss, New York, pp 29?37
4. Daugherty RL, Cockett ATK, Schoen SR, Schluss PM (1992) Suramin inhibits gonadotropin action in rat testes; implications for treatment of advanced prostatic cancer. J Urol 147:727
5. De Voogt HJ (1985) Second line endocrine management ? anti androgens and anti oestrogens. In: Schröder FH, Richards B (eds) EORTC GU-Group Monograph 2. Therapeutic principles in metastatic prostate cancer. Alan R. Liss, New York, pp 351?357
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献